Craigavon, Northern Ireland
The Almac Group is expanding its pharmaceutical R&D campus in Craigavon, Northern Ireland, with the construction of a $7.2 million formulation development facility. The scale-up laboratory will support early stage clinical development of solid oral dose drug products. Completion is expected in mid-2012. A second phase of expansion will include the construction of additional analytical and quality control labs, with completion slated for year-end 2012.
